Testing effectiveness (Phase 2)Study completedNCT00404495What this trial is testingCombination of Irinotecan and Temozolomide in Children With Brain Tumors.Who this might be right forGliomaMedulloblastoma Pfizer 83
Testing effectiveness (Phase 2)Study completedNCT00003173What this trial is testingHigh-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more Memorial Sloan Kettering Cancer Center 36
Early research (Phase 1)Active Not RecruitingNCT05768880What this trial is testingStudy of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System TumorsWho this might be right forDiffuse Intrinsic Pontine GliomaDiffuse Midline GliomaRecurrent CNS Tumor, Adult+2 more Seattle Children's Hospital 72
Early research (Phase 1)Study completedNCT01259479What this trial is testingSatraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain TumorsWho this might be right forSolid TumorsBrain TumorsBrain Metastases National Cancer Institute (NCI) 9
Post-approval studies (Phase 4)Active Not RecruitingNCT03016741What this trial is testingCognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerWho this might be right forCastration-Resistant Prostatic CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+2 more Northwestern University 100
Early research (Phase 1)Active Not RecruitingNCT06104488What this trial is testingAvutometinib for People With Solid Tumor CancersWho this might be right forRefractory CancerCNS TumorsCNS Tumor, Adult+12 more Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Study completedNCT00002750What this trial is testingMelphalan in Patients With Neoplastic MeningitisWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more Duke University 6
Early research (Phase 1)Looking for participantsNCT05521984What this trial is testingTargeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)Who this might be right forPediatric Brain TumorPediatric Solid Tumor Washington University School of Medicine 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432What this trial is testingBevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain MetastasesWho this might be right forBRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00393965What this trial is testingMultiple Dose Study of MPC-6827 in Subjects With Refractory Brain MetastasesWho this might be right forBrain Neoplasms Myrexis Inc. 18
Testing effectiveness (Phase 2)Study completedNCT02541370What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133Who this might be right forLiver CancerPancreatic CancerBrain Tumor+4 more Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07424092What this trial is testingIntratumoral DNX-2401 for High Grade Pediatric Brain TumorsWho this might be right forHigh Grade GliomaEpendymomaEmbryonal Tumor of Brain+4 more Clinica Universidad de Navarra, Universidad de Navarra 39
Early research (Phase 1)Study completedNCT00994500What this trial is testingVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02332655What this trial is testingCannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeWho this might be right forSturge-Weber Syndrome Anne Comi, MD 5
Early research (Phase 1)WithdrawnNCT01236586What this trial is testingRO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forLymphomaBrain NeoplasmsSarcoma+2 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT02617134What this trial is testingCAR-T Cell Immunotherapy in MUC1 Positive Solid TumorWho this might be right forMalignant Glioma of BrainColorectal CarcinomaGastric Carcinoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04270175What this trial is testingDaratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabWho this might be right forAmyloidAL AmyloidosisRefractory AL Amyloidosis Weill Medical College of Cornell University 15
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Not applicableLooking for participantsNCT05504772What this trial is testingPrecision Medicine for Every Child With CancerWho this might be right forChildhood CancerChildhood Solid TumorChildhood Brain Tumor+3 more Australian & New Zealand Children's Haematology/Oncology Group 3,500